E2F1 germline copy number variations and melanoma susceptibility

Melanoma is the most deadly form of skin cancer that arises from uncontrolled proliferation of melanocytes. Since it grows and spread quickly, prompt diagnosis, surgery and treatment are necessary to prevent the development of metastases.

Despite remarkable progress in the last few years in the detection and treatment of melanoma, the underlying molecular mechanism that triggers the development of melanoma is still poorly understood [1].

Melanoma is a very complex and heterogeneous type of cancer whose main risk factors are: exposure to ultraviolet radiations (UVR), phenotypic traits and genetic alterations [2, 3].

Genetic anomalies account for approximately 5–10% of melanoma cases with an autosomal dominant inheritance pattern [4]. Acquired or inherited genetic mutations are not the only genetic factors to cause melanoma; also structural chromosomal abnormalities, gain or loss of specific genomic regions, can contribute to an aberrant gene expression in melanocytes [5, 6].

In melanoma specific set of duplicated portions of chromosome 20 have been observed [7‐9] and, furthermore, most of the genes mapping on this chromosome were found to be upregulated in melanocytes in response to UV exposure [5]. The gene encoding for E2F1 transcription factor, which maps on chromosome 20, is found in multiple copies in both melanoma specimens and melanoma cell lines, resulting in the overexpression of the E2F1 protein [10]. E2F1 (UniprotKB: Q01094), belongs to the E2F family of transcription factor (TF), has a central role in regulating cell cycle progression and apoptosis [11, 12] and, therefore, E2F1 activity is tightly governed by multiple feedback mechanisms and by the tumour suppressor Rb. Given the pivotal role that E2F1 has in cell proliferation, its involvement in melanoma growth and progression is not surprising. In the last decade, germline CNVs in cancer-related genes, such as tumor suppressors or oncogenes, have been associated with cancer predisposition [13‐15]. This strongly supports the amplification of E2F1 gene in predisposing to cancer. Consistent with this, germline duplications of E2F1 gene have been recently observed in testicular cancer patients, suggesting a potential role of E2F1 copy number variations (CNVs) in the development of this type of cancer [16]. Whilst it has been established the somatic amplification of E2F1 in melanoma, germline E2F1 copy number in melanoma patients has never been determined, in this study, we wanted to verify whether pre-existing CNVs of this gene might also predispose to melanoma.

Furthermore, although several genetic alterations have been proven to be reliable predictors of melanoma, to date UVR exposure is recognized as the major environmental risk factor for this cancer. However, the mechanism underlying melanocyte transformation induced by UV radiations is still not fully elucidated.

Calapre et al. [17] hypothesized that the upregulation of heat shock proteins (HSPs), provoked either by exposure to UVR or heat, or by the combination of both factors, may be responsible for skin cancer development by promoting cell survival and proliferation. Therefore, we also wanted to investigate whether heat stress alone may cause deregulation of key genes known to be involved in melanocyte malignant transformation.

This is the first study showing an association between germline E2F1 CNVs and melanoma development, suggesting a role for germline E2F1 gains as a contributing risk factor for melanoma.

Moreover, this is the first study to demonstrate that genetic predisposition and environmental insults could act together to increase the risk of developing skin cancer. We demonstrate that heat stress could directly induce the mRNA expression of E2F1 in melanoma.

The most recognized environmental risk factor for melanoma are UVR as they cause formation of reactive oxidative species which severely damage cells and cause gene mutations. Mutations of CDKN2A gene account for roughly 20% of melanoma cases [18]. Furthermore, the deregulation of pRb pathway due to CDKN2A or CDK4 gene mutations is particularly frequent in melanomas arising from skin chronically exposed to sun [8]. The control of cell cycle entry is one of the most tightly controlled event that protects cells from uncontrolled proliferation and genomic instability. E2F1 regulates the G1/S entry by transcribing several genes necessary for DNA replication and cell cycle progression. In quiescent cells, E2F1 is inhibited by the Rb protein, which upon mitogenic stimulation is phosphorylated and releases E2F1. Several oncogenes inactivate Rb and loss of the E2F1 negative feedback system allows the uncontrolled proliferation of cancer cells. The deregulated activity of E2F1 protein could also be the result of chromosomal rearrangements involving E2F1 gene, such as CNV encompassing E2F1 gene, as demonstrated by this and our previous studies (Table 1 and ref. [16]). We previously reported germline gains of E2F1 in men with testicular cancer (13). We found that individuals harbouring constitutive duplications of this gene are more likely to develop this form of cancer and to be infertile [16]. Alarmingly, overexpression of E2F1 protein was found in the testicular tissue of a testicular cancer patient who had multiple germline copies of E2F1 (13). Even though it remains to be further elucidated which molecular pathways are involved in the upregulation of E2F1 protein, this finding strongly suggests a contribution of germline E2F1 copy numbers in rendering this individual particularly susceptible to cancer of the testis. In addition to an increased risk for testicular cancer, subjects with altered germline E2F1 copies are potentially at risk of developing also melanoma, since E2F1 was also found in multiple copies in many melanoma cases [10]. Testicular cancer has been, therefore, associated with an increased risk for melanoma [19], suggesting that these two cancers share common environmental and genetic factors.

In this study we report that germline gains of E2F1 also occur in a relevant number of melanoma patients (Table 1). These gains were absent in individuals not affected by melanoma, whereas all subjects with multiple copies of E2F1 had melanoma. These results imply that the acquisition of additional germline copies of E2F1 could predispose to melanoma later in life.

Although it is undeniable that E2F1 acts as oncogene in several cancers, including in melanoma, to the extent that it has been proposed as a new therapeutic target [20], it is not clear which molecular mechanism triggers the transcription of E2F1 and consequently lead to the neoplastic transformation of melanocytes. Our recent discovery of E2F1 expression induced by heat [21], suggests that this condition, might be the one context in which this genetic alteration could cause the overexpression of E2F1 protein and its activity leading to the uncontrolled proliferation of melanocytes.

Heat stress has been, furthermore, recently indicated as potential risk factor for skin cancer, since it could trigger the transcription of HSPs in melanocytes, promoting cell proliferation and survival [17]. The detrimental effect of temperature has been already reported also in other form of cancers, such as oesophageal cancer, where chronic heat exposure leads to tumorigenesis [22]. Interestingly, in this study we demonstrate that heat stress stimulate the expression of E2F1 mRNA in melanoma cell line which further supports its role as potential risk factor for melanoma.

However, CNV amplification does not necessarily lead to overexpression of the gene encoded within the CNV. We hypothesize that stress conditions, such as heat, could trigger the transcription and consequently the translation of E2F1 protein. Indeed, considering that one genetic alteration is generally insufficient to induce melanoma, it is likely that the combination of environmental and genetic factors are necessary for the onset of melanoma.

This study suggests a potential role of CNV in tumorigenesis as we found an association between germline E2F1 CNV and melanoma, however, further studies are needed in order to determine whether the additional E2F1 copy was acquired de novo or inherited. Furthermore, information on the lifetime exposure to high temperature of the subjects would also be necessary to understand the impact that it might have had on the timing and site of melanoma manifestation.

The identification of downstream targets of heat inducing E2F1 activity in melanoma could provide further insight on the underlying molecular pathways that lead to the development of this cancer.